The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Konverge 40mg/10mg film-coated tablets

40/10 mg/mg Film-coated tablet

IMED Healthcare Ltd.PPA1463/104/003

Main Information

Trade NameKonverge 40mg/10mg film-coated tablets
Active SubstancesOlmesartan medoxomil
Amlodipine besylate
Strength40/10 mg/mg
Dosage FormFilm-coated tablet
Licence HolderIMED Healthcare Ltd.
Licence NumberPPA1463/104/003

Group Information

ATC CodeC09DB Angiotensin II antagonists and calcium channel blockers
C09DB02 olmesartan medoxomil and amlodipine

Status

Authorised/WithdrawnAuthorised
Licence Issued04/12/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0046-093-003
Interchangeable List DocumentPDF of Interchangeable List
« Back